What Is Wellgistics Health, Inc. (WGRX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Wellgistics Health, Inc.'s intrinsic value is estimated at $1.99. Trading at its current price of $2.94, the valuation engine raises significant caution: 7 of 9 models flag downside risk, projecting an average implied return of -32.2%. Notably, PWERM sees the most upside at +298.0% (fair value: $11.70), while ML-RIV is the most conservative at -99.8% ($0.01). The spread between these extremes — +397.8% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About WGRX?
9 of 13 models are currently active for WGRX. Of these, 2 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates WGRX's intrinsic value at $1.06, implying -64.0% downside from the current price. See which stocks rank higher →
How Does WGRX Rank in Wholesale-Drugs, Proprietaries & Druggists' Sundries?
Among 10 Wholesale-Drugs, Proprietaries & Druggists' Sundries stocks, WGRX ranks #9 by Quality of Company score. CirclFi's QOC score of 3.7/10 evaluates 32 fundamental signals. A score of 3.7 signals below-average fundamentals.
The Wholesale-Drugs, Proprietaries & Druggists' Sundries sector introduces analytical considerations specific to healthcare company businesses. For Wellgistics Health, Inc., metrics like patent cliff exposure provide important context that general-purpose valuation models may underweight.
Is WGRX a Value Trap?
CirclFi's Value Trap algorithm assigns WGRX a score of 5/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Wellgistics Health, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Wellgistics Health, Inc. scores 3.7 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +397.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every WGRX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across WGRX's 9 active models, average confidence is 28%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad